Acrp30 Human, Sf9

Adiponectin Human Recombinant, Sf9
Cat. No.
BT6474
Source
Sf9, Baculovirus cells.
Synonyms

Adiponectin, C1Q And Collagen Domain Containing, Adipose Most Abundant Gene Transcript 1 Protein, Adipocyte Complement-Related 30 KDa Protein, 30 KDa Adipocyte Complement-Related Protein, ACRP30, APM-1, GBP28, ACDC, APM1, Adipocyte, C1q And Collagen Domain-Containing Protein, Adipocyte, C1Q And Collagen Domain Containing, Adipose Most Abundant Gene Transcript 1, Adipose Specific Collagen-Like Factor, Gelatin-Binding Protein 28, Gelatin-Binding Protein, Adiponectin Precursor, Adiponectin, ADIPQTL1, ADPN, 30 kDa adipocyte complement-related protein, dipocyte complement-related 30 kDa protein, ACRP30, Adipocyte, C1q and collagen domain-containing protein, Adipose most abundant gene transcript 1 protein, apM-1, Gelatin-binding protein.

Appearance
Sterile Filtered clear solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Acrp30 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 146 amino acids (106-242a.a.) and having a molecular mass of 16.9kDa. (Molecular size on SDS-PAGE will appear at approximately 13.5-18kDa). Acrp30 is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Adiponectin (Acrp30), exclusively produced and secreted by adipose tissue, plays a crucial role in various physiological processes, including energy balance, insulin sensitivity, hormonal regulation, fatty acid metabolism, and obesity. Circulating in plasma, Acrp30 levels decrease in conditions like insulin resistance and hyperinsulinemia, commonly observed in individuals with obesity, insulin resistance, and type 2 diabetes. Structurally, Acrp30 consists of an N-terminal collagenous domain followed by a C-terminal globular domain. Furthermore, Acrp30 acts as a significant negative regulator in hematopoiesis and immune responses, potentially contributing to the resolution of inflammation through its inhibitory effects. It inhibits endothelial NF-kappa-b signaling via a cAMP-dependent pathway and suppresses TNF-alpha-induced expression of endothelial adhesion molecules.
Description
Recombinant Human Acrp30, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain comprising 146 amino acids (106-242a.a.). With a molecular mass of 16.9 kDa, it appears at approximately 13.5-18 kDa on SDS-PAGE. The protein is expressed with a 6 amino acid His tag at the C-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The Acrp30 protein solution is provided at a concentration of 0.5 mg/ml and contains Phosphate Buffered Saline (pH 7.4) and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), store the entire vial at 4°C. For extended storage, freeze at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the protein is greater than 95.0% as determined by SDS-PAGE.
Synonyms

Adiponectin, C1Q And Collagen Domain Containing, Adipose Most Abundant Gene Transcript 1 Protein, Adipocyte Complement-Related 30 KDa Protein, 30 KDa Adipocyte Complement-Related Protein, ACRP30, APM-1, GBP28, ACDC, APM1, Adipocyte, C1q And Collagen Domain-Containing Protein, Adipocyte, C1Q And Collagen Domain Containing, Adipose Most Abundant Gene Transcript 1, Adipose Specific Collagen-Like Factor, Gelatin-Binding Protein 28, Gelatin-Binding Protein, Adiponectin Precursor, Adiponectin, ADIPQTL1, ADPN, 30 kDa adipocyte complement-related protein, dipocyte complement-related 30 kDa protein, ACRP30, Adipocyte, C1q and collagen domain-containing protein, Adipose most abundant gene transcript 1 protein, apM-1, Gelatin-binding protein.

Source
Sf9, Baculovirus cells.
Amino Acid Sequence

ADPEGAYVYR SAFSVGLETY VTIPNMPIRF TKIFYNQQNH YDGSTGKFHC NIPGLYYFAY HITVYMKDVK VSLFKKDKAM LFTYDQYQEN NVDQASGSVL LHLEVGDQVW LQVYGEGERN GLYADNDNDS TFTGFLLYHD HHHHHH.

Product Science Overview

Introduction

Adiponectin, also known as Acrp30, AdipoQ, and GBP28, is a protein hormone predominantly secreted by adipose tissue. It plays a crucial role in regulating metabolic processes such as glucose regulation and fatty acid oxidation. The recombinant form of adiponectin, produced in Sf9 Baculovirus cells, is a valuable tool for research and therapeutic applications.

Structure and Production

Adiponectin is a glycosylated polypeptide chain containing 146 amino acids (106-242 a.a.) with a molecular mass of approximately 16.9 kDa . The protein is expressed with a 6 amino acid His tag at the C-terminus and purified using proprietary chromatographic techniques . The modular structure of adiponectin comprises an N-terminal collagenous domain followed by a C-terminal globular domain .

Biological Functions

Adiponectin is involved in various physiological processes, including:

  • Energy Homeostasis: It helps regulate energy balance by enhancing insulin sensitivity and promoting fatty acid oxidation .
  • Insulin Sensitivity: Adiponectin improves insulin sensitivity, making it a key player in glucose metabolism .
  • Hormonal Processes: It influences hormonal activities related to metabolism .
  • Fatty Acid Metabolism: Adiponectin promotes the breakdown of fatty acids, contributing to lipid metabolism .
Pathophysiological Implications

Decreased levels of adiponectin are associated with several metabolic disorders, including:

  • Insulin Resistance: Low adiponectin levels are linked to insulin resistance, a hallmark of type 2 diabetes .
  • Obesity: Individuals with obesity often exhibit reduced adiponectin levels, which can contribute to metabolic complications .
  • Cardiovascular Diseases: Adiponectin has anti-inflammatory properties and can inhibit endothelial NF-kappa-B signaling, reducing the risk of cardiovascular diseases .
Therapeutic Potential

Adiponectin’s role in metabolic regulation makes it a promising candidate for therapeutic applications. Potential areas of research and treatment include:

  • Metabolic Disorders: Enhancing adiponectin levels could improve insulin sensitivity and glucose metabolism in individuals with type 2 diabetes and obesity .
  • Cardiovascular Health: Adiponectin’s anti-inflammatory properties may help mitigate the risk of cardiovascular diseases .
  • Inflammatory Responses: By inhibiting TNF-alpha-induced expression of endothelial adhesion molecules, adiponectin may play a role in controlling inflammatory responses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.